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WOODS, J. H., C. R. SCHUSTER AND C. R. HARTEL. Behavioral effects ofthebaine in the rhesus monkey. PHAR- 
MAC. BIOCHEM. BEHAV. 14(6) 805-809, 1981.--Three experiments were conducted with rhesus monkeys to assess 
some behavioral effects of the opium alkaloid, thebaine, in relation to its dependence liability. The concurrent 
intramuscular administration of naloxone did not antagonize the rate-decreasing effects of thebaine on a fixed-ratio (FR) 
schedule of food-reinforced responding. Animals trained to self-administer codeine (0.3 mg/kg/inj) on an FR 30 schedule did 
not self-administer thebaine (0.003-1.0 mg/kg/inj) at rates comparable to those of codeine. Rates were minimally above 
those of saline at 0.3 mg/kg inj. Monkeys given 23 hrs/day continuous access to 1.0 mg/kg/inj thebaine did, however, 
self-administer the drug at rates significantly higher than those maintained by saline, but not as high as those supported by 
2.0 mg/kg/inj codeine. Two animals self-administering thebaine did not show any signs of withdrawal when injected with 
0.1-1.0 mg/kg of naloxone or when saline was substituted for thebaine. A third monkey showed a severe reaction leading to 
death following an injection of 1.0 mg/kg naloxone. 
Thebaine Codeine Naloxone Food-reinforced responding 
THEBAINE is an opium alkaloid which shows little, if any, 
analgesic action in common with morphine; although it does 
produce seizures [7]. Recent research interest in the phar- 
macology and the behavioral effects of thebaine has gener- 
ated conflicting reports on its ability to produce dependence 
of the morphine type. Yanagita et al. [14] have reported that 
rhesus monkeys became physically dependent on thebaine 
as shown by naloxone and deprivation withdrawal tests. 
Thebaine, unlike codeine, did not suppress morphine with- 
drawal signs in morphine-dependent monkeys; rather, it 
produced signs resembling morphine withdrawal in these 
animals. Yanagita et al. [14] also reported that monkeys 
self-administered thebaine at rates higher than those for 
saline, but lower than those maintained by codeine. 
Thebaine has not been found to produce physical depend- 
ence in other species. Harris [6] found no evidence of physi- 
cal dependence in rats given continuous infusions of 
thebaine at various doses for a seven-day period and then 
abruptly withdrawn from the drug. Gilbert and Martin [4] 
reported that thebaine did not produce any morphine-like 
effects in non-dependent chronic spinal dogs. Thebaine did 
not precipitate an abstinence syndrome in morphine- 
dependent dogs, although the authors pointed out that the 
excitatory actions of thebaine are similar to those of the 
withdrawal syndrome, and this might explain the interpreta- 
tion of the signs reported by Yanagita et al. [14]. These au- 
thors did, however, note a slight effect of naloxone in the dog 
given chronic thebaine. 
In an evaluation of the discriminative effects of narcotics 
in the rat [9], thebaine failed to produce morphine-like ef- 
fects, while other narcotics did so. 
The purpose of these experiments was to examine further 
the reinforcing effect of thebaine under two types of experi- 
mental conditions. In addition, observations were gathered 
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on thebaine's direct effects on food-reinforced responding 
and the nature of the effects as revealed by antagonism 
studies with naloxone. 
GENERAL METHOD 
Subjects 
Subjects in these experiments were l l rhesus monkeys 
weighing between 5.0 and 8.0 kg. The seven monkeys in 
experiments requiring intravenous drug self-administration 
were prepared with surgically implanted intravenous cathe- 
ters [1]. These monkeys were permanently housed in their 
experimental cubicles, where they had free access to food 
and water. The remaining four monkeys were housed in in- 
dividual housing cages. They were placed, for each experi- 
mental session, in primate restraining chairs which were in- 
serted in sound-attenuated chambers with two response lev- 
ers and an array of stimulus lights. These monkeys were 
deprived to 80% of their free-feeding weights and maintained 
at this level throughout this experiment. Experimental con- 
ditions were controlled and data recorded by automatic pro- 
gramming equipment located in an adjacent room. 
Drugs 
Thebaine ethanoate was dissolved and diluted in 0.9% 
saline solution. Thebaine HC1 was dissolved in distilled 
water and buffered to a pH of 4.5 for use in Experiment 3. 
Drug was prepared every other day. Doses of thebaine are 
expressed as the salts in Experiments 1 and 2; free base in 
Experiment 3. Codeine and naloxone were dissolved and 
diluted in 0.9% saline solution; doses are expressed as salts. 
All the intramuscularly administered drugs were injected 
into the thigh muscle in a volume of 1 cc. When two drugs 
were administered concurrently, injections were made a few 
seconds apart into different intramuscular sites. 
EXPERIMENT l: THEBAINE AND ITS INTERACTION 
WITH NALOXONE 
METHOD 
Four food-deprived monkeys were used that had an ex- 
tensive history with the particular schedule of food presen- 
tation employed. Thirty responses on a key, mounted di- 
rectly in front of the restraint chair, produced a 300 mg 
banana-flavored food pellet. Following food delivery, the 
lights in the chamber changed and responses on the key de- 
layed, for 30 additional sec, the condition in which 30 re- 
sponses led to food presentation. Technically, this schedule 
of reinforcement [2] may be designated as a chain differential 
reinforcement of other behavior (DRO); fixed-ratio (FR). If 
30 responses were not completed within 1 min, the FR com- 
ponent was terminated and the DRO component came into 
effect. Each session lasted about one hour. 
When behavior had stabilized on this schedule, animals 
were injected with saline or thebaine immediatley prior to 
the experimental session. Doses of thebaine were 0.32, 1.0, 
1.78, and 3.2 mg/kg and were given twice to each monkey in 
a mixed order. Subsequently, the two larger doses of 
thebaine were repeated, and on alternate drug administration 
sessions, naloxone (0.1 or 1.0 mg/kg) was administered con- 
currently. In separate sessions, naloxone was given alone. 
As a positive control, prior to other sessions, morphine (3.2 
mg/kg) was given to suppress the rates of responding and it 
was combined with naloxone (0.03 mg/kg). 
RESULTS 
Saline, 0.32 and 1.0 mg/kg thebaine did not affect re- 
sponse rates during the FR component of the schedule (Fig. 
la). The two larger doses of thebaine decreased responding 
in a dose-dependent fashion: 1.78 mg/kg reduced responding 
from 4.46_+0.33 (S.E.M.) resp/sec to 2.87_+1.79 resp/sec, 
while 3.2 mg/kg thebaine reduced responding to 1.35_+0.59 
resp/sec. 
Naloxone (0.1 and 1.0 mg/kg) was administered concur- 
rently either with 1.78 or with 3.2 mg/kg thebaine to deter- 
mine whether these rate-suppressing effects could be antag- 
onized. These doses of naloxone alone reduced slightly re- 
sponse rates from those observed with saline controls. Fig. 
lb shows that neither dose of naloxone reversed the rate- 
suppressing effects of either 1.78 or 3.2 mg/kg thebaine. 
Clearly, naloxone did not antagonize the effects of thebaine 
on operant responding for food; rather it may have slightly 
augmented the rate-reducing effects of thebaine. Morphine 
reduced FR responding to 0.32 resp/sec (N=4); naloxone 
reversed these effects completely (4.20 resp/sec; N=4). 
EXPERIMENT 2: THEBAINE SELF-INJECTION--  
SUBSTITUTION FOR CODEINE 
METHOD 
Three monkeys with experimental histories of codeine 
self-injection were permanently housed in open-faced cubi- 
cles equipped with 2 response levers and an array of stimulus 
lights. The animals were restrained in these cubicles by a 
harness and tubular stainless steel arm as described by De- 
neau et al. [1]. The animals' surgically implanted intravenous 
catheters were connected through their restraining arms to 
injector devices. The monkeys were conditioned to self- 
inject codeine on a fixed-ratio 30, 10 min timeout procedure 
as described by Woods [10]. 
RESULTS 
After responding for codeine had stabilized on this 
schedule, saline or thebaine in doses ranging from 0.003 to 
1.0 mg/kg/injection was substituted for the codeine in single 
experimental sessions. The animals uniformly took all the 
codeine injections available to them during the session (a 
maximum of 13). When saline was substituted for codeine, 
the average number of injections taken per session decreased 
to 8.4_+ 1.3 (S.E.M.). Substitution of thebaine produced no 
increase in the number of injections taken, except possibly 
for 1.0 mg/kg/inj (10.1 infusions). Fixed-ratio response rates 
over most thebaine doses studied were no higher than those 
for saline, and in all cases, they were lower than those for 0.3 
mg/kg codeine (Fig. 2). Response rates during the time out 
period, while the drug pump was running, or those associ- 
ated with the non-drug lever did not vary significantly under 
the various conditions of codeine, saline, and thebaine self- 
injection. 
EXPERIMENT 3: THEBAINE SELF- 
ADMINISTRATION UNDER UNLIMITED ACCESS 
AND ITS INTERACTION WITH NALOXONE 
METHOD 
Four naive monkeys were prepared with intravenous 
catheters. These monkeys were permanently housed in 
sound-attenuating wooden cubicles, each equipped with a 
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FIG. 1. (a) The effects of thebaine on FR response rates. Each point is the mean of 8 observations (2 determinations in 4 
monkeys). Abscissa: dose, mg/kg (log scale). Ordinate: response rate (resp/sec) during the FR portion of the schedule. SAL: saline 
control. Vertical bars: S.E.M. (N=4). FIG. 1. (b) The effects of saline or thebaine administered concurrently with either saline or 
naloxone. Abscissa: The three bars on the left indicate saline, 1.78 mg/kg thebaine and 3.2 mg/kg thebaine administered with 
saline. The three bars in the middle indicate the same three doses administered with 0.1 mg/kg naloxone; the three on the right, 
with 1.0 mg/kg naloxone. Ordinate: response rate (resp/sec) during the FR portion of the schedule. Vertical bars: S.E.M. (N =4). 
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FIG. 2. Fixed-ratio 30 response rate maintained by codeine (0.3 
mg/kg/inj), saline, and thebaine (0.003-1.0 mg/kg). Each dose of 
thebaine and saline was evaluated twice in each of three monkeys. 
Codeine was used to maintain the performance and six sessions 
were randomly chosen and averaged for comparison. Brackets indi- 
cate the standard error of the average (N=3). 
drug infus ion  pump ,  house l igh ts ,  and  two r e sponse  levers  
with  s t imulus  lights.  The  an imals  were  r e s t r a ined  wi th in  the i r  
cubic les  with  s ta inless  steel  spr ing a rms  and  h a r n e s s e s  as 
desc r ibed  by S c h u s t e r  and  J o h a n s o n  [8]. 
M o n k e y s  were  a l lowed 23 hours  pe r  day c o n t i n u o u s  ac- 
cess  to saline.  Each  r e sponse  on  the  des igna ted  lever  (FR 1) 
de l ivered  a 10 sec in jec t ion  of  saline,  dur ing  which  the  
house l igh ts  were  t u rned  off  and  a red in jec t ion light was  
tu rned  on. Sal ine was ava i lab le  for  the  first  s even  days  fol- 
lowing surgery .  
T h e b a i n e  ( e thanoa te  or  H C L ) ,  1.0 mg base /kg/ in jec t ion ,  
was  subs t i t u t ed  for saline on the  e ighth  day  and its availabil-  
ity c o n t i n u e d  on  the F R  1 unti l  the  an imal s '  in take  s tabi l ized 
(2-5 weeks) .  A single m o n k e y  (no. 93) was  g iven  hour ly  
in ject ions  (1 mg/kg) for  five consecu t ive  days  af te r  a week  of  
exposu re  to the  drug dur ing  which  r e spond ing  was  not  ini- 
t iated.  Fol lowing s tabi l iza t ion  of  r e spond ing  ma in t a ined  
u n d e r  the FR 1 schedule ,  the  f ixed rat io va lues  were  in- 
c r eased  f rom ! to 3, 5, and  finally 10 at in te rva ls  of  approx-  
imate ly  5 days  for all animals .  
U n d e r  the  FR 10 schedule ,  a single admin i s t r a t ion  of  0. l,  
0.3, or  1.0 mg/kg na loxone  was g iven  at 3-4  day in te rva ls  in 
mixed order .  Changes  in t heba ine  self- inject ion were  re- 
co rded  and  gross  changes  in b e h a v i o r  were  o b s e r v e d  conse-  
q u e n t  to na loxone  admin i s t ra t ion .  Saline was subs t i tu t ed  for  
t heba ine  and  changes  in sel f - inject ion r e spond ing  were  re- 
co rded  and  o b s e r v a b l e  signs of  behav io ra l  change  no ted  o v e r  
a four  day period.  
In two m o n k e y s ,  code ine  was subsequen t l y  made  avail-  
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FIG. 3. Mean number of 1.0 mg/kg thebaine infusions taken during 
the last three days at various fixed ratio values in Experiment 3. S: 
saline infusions taken on FR I schedule before thebaine was intro- 
duced. Sz: saline infusions taken on an FR 10 schedule after thebaine 
was discontinued. Numbers in parentheses indicate mean number of 
days at each ratio value. 
able at a dose of  2.0 mg/kg/inj at FR  10 under  23 hr access  
condit ions.  Subsequent  to two weeks of  exposure ,  the same 
doses  of  naloxone were given and changes in observable  
behavioral  signs were  noted and changes in self-injection 
responding were recorded.  
RESULTS 
The monkeys  took be tween  0 and 5 infusions of  saline per  
23 hr session (Fig. 3). When thebaine was substi tuted for 
saline, three of  the four  monkeys  spontaneously  increased 
responding until they were  taking an average of  22.7 injec- 
t ions/session.  The fourth monkey ,  animal no. 93, did not 
self-inject thebaine until hourly infusions of  the drug were 
programmed for five consecut ive  days. After  these non- 
cont ingent  injections she began responding for thebaine at a 
rate similar to that of  the o ther  animals.  When the FR re- 
qui rement  was increased from I to 10, the average number  of 
inject ions/session for all monkeys  decreased  slightly to 18.9. 
FR responding was of  the typical break and run pattern [2]. 
The three monkeys  were given IM doses  of  naloxone on 
different days immediate ly  before the start of  a daily session. 
The first monkey ,  no. 83, rece ived  1.0 mg/kg naloxone as her 
first dose.  Within 25 min of  the naloxone injection, she began 
lying down,  was hyper-irr i table and retching. The animal did 
not increase responding for thebaine during the period fol- 
lowing the naloxone injection, but her responding on the 
non-drug lever  greatly increased from the average of  3 re- 
sponses/sess ion to 35 in the first hour of  the naloxone pre- 
t reatment  session. Two hours later the animal was no longer 
hyper-irr i table or  retching, but was lying down and showing 
tension. The monkey was observed  for four  hours after the 
naloxone injection,  at which time these physical signs had 
subsided. She was found dead in her cubicle the next morn- 
ing, clearly not from convuls ions ,  since no contusions or 
abrasions were noted. 
The two remaining monkeys ,  no. 92 and no. 65, com- 
pleted their series of  naloxone injections and, as can be seen 
from Table 1, in no case did thebaine intake increase ei ther  
during the first hour  of  the session after the injection or  
during the entire 23 hr session. Rather  there was ei ther  no 
change or  decreases  in intake ove r  these time periods.  Fur- 
thermore ,  neither animal showed signs of  gross behavioral  
change at any dose of  naloxone.  After  complet ing this series 
of  naloxone injections,  saline was substi tuted for thebaine in 
each animal and responding declined ove r  several sessions to 
an average of  2 to 6 infusions of  saline per  day (Fig. 3). 
Nei ther  monkey  showed any signs of  gross behavioral  
change when the substitution was made. 
As a compar ison  exper iment ,  with monkeys  no. 93 and 
no. 65, codeine (2.0 mg/kg/infusion) was then substituted for 
saline. Within 3 days,  monkey no. 65 began taking between 
10 and 20 infusions of  codeine  per day,  and within two weeks 
the intake had increased to an average 130 infusions per day. 
At this point she died of  non-exper imental ly  related causes.  
The second code ine-exposed  monkey,  no. 92, also increased 
responding for codeine  until he was taking an average of 56 
infusions per 23 hr session. After  codeine intake had 
stabilized, he was then pretreated on different days with 0.1, 
0.3, or  1.0 mg/kg of  naloxone.  He showed mild signs of  with- 
drawal at the two lower  doses  (excessive vocal izat ions,  mild 
irritability) and more severe  symptoms (extreme irritability 
T A B L E  1 
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Hour l 23 Hours 
Saline 4* 36 3 18 I 12.5 5.7 55.7 
0 . 1 0  - -  - -  4 4 2 7 10 34 
0.30 - -  - -  0 8 - -  - -  3 49 
1.0 3 death 0!l-I 4/14 1 10 4 62 
*Number of infusions. 
~This dose was tested twice in animal No. 65. 
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and activity, bizarre postures, retching) at the 1.0 mg/kg 
dose. The animal did not significantly change his codeine 
intake after nay of the naloxone pretreatments either in the 
first hour or during the rest of the post-naloxone sessions 
(Table 1). 
G E N E R A L  DISCUSSION 
Thebaine self-injection was maintained under 23-hr un- 
limited access conditions, but, under the FR 30 timeout 10 
min schedule, the rate of responding was only marginally 
above that generated by the saline vehicle (Figs. 2 and 3). 
Yanagita and Miyasato [13] reported similarly that self- 
injection of thebaine under 4-hr access, FR 1 was only mar- 
ginally above saline; however, under unlimited access FR 1 
conditions, both we and Yanagita and his colleagues found 
that 0.1 to 1.0 mg/kg would maintain stable levels of respond- 
ing above vehicle. It is likely that these same patterns of 
self-injection will be found across different contingencies 
with other drugs, e.g., barbiturates and benzodiazepines 
[5,15], and clonidine [11]. There are at least two potiential 
explanations for the difference in self-injection results under 
different access conditions. One is that cost/reinforcement as 
defined by response requirement and availability differ in a 
functional way between the two conditions. A second 
possibility is that weak reinforcers maintain behavior only 
slightly above their vehciles. Compared over  short periods of 
exposure the difference may be insignificant; with longer 
exposure, smaller differences become relatively more impor- 
tant. 
Thebaine is a close chemical congener of codeine and 
morphine but its acute and chronic effects differ significantly 
from them. In the monkey, at doses of 4-8 mg/kg, thebaine 
produced tremor, restlessness, hyper-irritability, and slight 
motor impairment [13]; note that these doses are larger than 
those necessary to completely suppress food-reinforced re- 
sponding (Fig. I). In the dog, Gilbert and Martin [4] reported 
that thebaine did not produce any morphine-like effects in 
nondependent dogs. Yanagita and Miyasato [13] reported 
that the effects of thebaine, rather than substituting for those 
of morphine, resembled to some extent the withdrawal syn- 
drome produced by morphine antagonists. The signs ob- 
served in the dependent and nondependent monkey were 
discriminably different. This was not found to be the case in 
dogs, in that thebaine produced signs that were comparable 
in kind and magnitude in morphine-dependent and non- 
dependent dogs [4]. 
Nevertheless, there are some common actions of thebaine 
and morphine. At appropriate doses, these compounds 
produce rate reductions of food-reinforced responding. In 
higher doses in rodents they will induce convulsions. These 
common actions may be mediated by different mechanisms 
since naloxone has the capacity to antagonize morphine's 
actions to a far greater extent than those of thebaine in either 
species (Fig. 1; [3]). 
Thebaine has been shown not to produce a deprivation- 
withdrawal syndrome following its chronic administration to 
either rats [6] or dogs [4]. Our findings are in agreement; on 
the other hand, Yanagita and Miyasato [13] found in rhesus 
monkeys both deprivation and antagonist-induced with- 
drawal syndromes. In one of the three monkeys in the pres- 
ent experiment, naloxone produced a strong reaction cul- 
minating in death. It is of interest to note that this animal was 
self-administering larger amounts (ca. 30 mg/kg/day) than the 
two monkeys that showed no reaction to naloxone. These 
data taken together with those of Yanagita and Miyasato [13] 
suggest dependence may develop, and that it should be 
studied further under conditions involving over 30 mg/kg/day 
of thebaine intake. 
The findings of the present study, in general, agree with 
those cited above in showing that there are a number of acute 
actions of thebaine that are unlike those of morphine. The 
question of thebaine dependence requires further considera- 
tion; Yanagita et al. [14] have suggested that an active 
metabolite of thebaine, oripavaine may play a role in 
thebaine's dependence-producing capacity. Oripavaine has 
been found by Yamazoe et al. [12] in the urine of thebaine- 
treated monkeys. This compound should be examined di- 
rectly to determine whether its potency is sufficient to ac- 
count for the dependency produced by thebaine. 
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